Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Lanxess AG    LXS   DE0005470405

LANXESS AG

(LXS)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 12/01 03:59:59 pm
59.22 EUR   +0.95%
12:07pLANXESS : increases prices for adipic acid
PU
10:01aLANXESS AG : NorldLB sticks Neutral
MD
11/30LANXESS : increases black pigment capacity
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • Its low valuation, with P/E ratio at 5.71 and 17.43 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at EUR 60.44.
  • Technically, the stock approaches a strong medium-term resistance at EUR 59.48.
  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart
Sector Diversified Chemicals
1st jan.Capitalisation (M$)Investor Rating
LANXESS AG-1.94%6 054
SHIN-ETSU CHEMICAL CO., LTD..42.08%68 186
BASF SE-8.94%67 324
DUPONT DE NEMOURS, INC.-1.18%46 555
ROYAL DSM N.V.18.26%27 826
FMC CORPORATION15.88%15 053
EVONIK INDUSTRIES AG-6.98%14 071
ASAHI KASEI CORPORATION-22.44%12 727
BRENNTAG AG32.14%11 829
PIDILITE INDUSTRIES LIMITED10.21%10 493
SHANDONG HAIHUA CO, NULL, L..76.65%8 681
NISSAN CHEMICAL CORPORATION35.80%8 620
MITSUBISHI CHEMICAL HOLDING..-29.36%7 860
SUMITOMO CHEMICAL COMPANY, ..-25.70%5 794
TOSOH CORPORATION-2.89%5 019
SASOL LIMITED-60.20%4 904
More Results
Financials
Sales 2020 6 051 M 7 282 M 7 282 M
Net income 2020 858 M 1 033 M 1 033 M
Net Debt 2020 1 293 M 1 556 M 1 556 M
P/E ratio 2020 5,71x
Yield 2020 1,55%
Capitalization 5 065 M 6 054 M 6 095 M
EV / Sales 2020 1,05x
EV / Sales 2021 0,96x
Nbr of Employees 14 351
Free-Float 90,1%
Upcoming event on LANXESS AG
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes